Acorda Therapeutics Inc (ACOR)

NASDAQ
3.870
+0.150(+4.03%)
After Hours
3.940
+0.070(+1.809%)
- Real-time Data
  • Volume:
    423,740
  • Bid/Ask:
    3.860/3.950
  • Day's Range:
    3.660 - 4.004

ACOR Overview

Prev. Close
3.72
Day's Range
3.66-4.004
Revenue
153.73M
Open
3.7
52 wk Range
2.534-9.84
EPS
-15.25
Volume
423,740
Market Cap
36.72M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,105,595
P/E Ratio
-
Beta
0.65
1-Year Change
1.45%
Shares Outstanding
9,488,596
Next Earnings Date
Aug 05, 2021
What is your sentiment on Acorda Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Acorda Therapeutics Inc News

Acorda Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellSellStrong Sell
Technical IndicatorsStrong SellBuyStrong BuySellStrong Sell
SummarySellNeutralNeutralSellStrong Sell

Acorda Therapeutics Inc Company Profile

Acorda Therapeutics Inc Company Profile

Employees
167

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol dependence; and Inbrija for the treatment of OFF periods in Parkinson’s disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.

Read More
  • It will be up!
    0
    • Mr Cohen what do you make with money of the investors
      0
      • Israeli CEO what you expect, look at the stock price since 3 years - trash
        0
        • Nice targets, after 2 years maybe...
          0
          • Entered with 12.000€ at 4.82. Target price 5.90 in 3 days at most.
            1
            • NicolaWISH you good luckAcora targe price change from 5 to $10
              0
          • Soon will be 14$
            1
            • Never
              0
          • Did you guys noticed that?
            0
            • Hi guys is anyone of you aware that this company had a consolidation on the 4th of January, where you were given 1share for every 6 shares, for example if you had 12 shares before the 4th, you now have 2. And the price also went up from 75cents to 3.75 dollars...
              0
              • I'm in $6,1. I'm a crazy guy :)
                0
                • 🚀🚀🚀
                  0
                  • i belive will arrive to 7 end of the week
                    0
                    • um
                      0
                      • lol
                        0
                        • Short asap
                          1
                          • hope they will not do RS
                            0
                            • 🌡🚀
                              0
                              • see you at 3
                                0
                                • Why is this stock so unknown? Low price vs intrensic value, revenue is going up 3 quarters and they have a positive net income again. so what is wrong with it?
                                  0
                                  • 🚀
                                    0
                                    • what happened
                                      0
                                    • What is the news ?
                                      0
                                  • Subira a 2dol est accion?
                                    0
                                    • This stock will reach 2 soon
                                      0
                                      • Earning tonight?
                                        0
                                      • I dont know sure
                                        0
                                    • Is the earnings date today guys? Everywhere another date
                                      0
                                      • "Acorda Therapeutics, Inc. is estimated to report earnings on 11/02/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 0 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.47. The reported EPS for the same quarter last year was $-0.52.'
                                        0
                                    • ACOR is continously going down today? Any idea or news for this stock?
                                      0
                                      • hello! where to buy it? any broker?
                                        0
                                        • Maybe down +/-20%
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.